| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1934189
Max Phase: Preclinical
Molecular Formula: C19H11ClN6
Molecular Weight: 358.79
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Clc1ccc(-c2nc3cc(-c4nnn[nH]4)ccc3c3cnccc23)cc1
Standard InChI: InChI=1S/C19H11ClN6/c20-13-4-1-11(2-5-13)18-15-7-8-21-10-16(15)14-6-3-12(9-17(14)22-18)19-23-25-26-24-19/h1-10H,(H,23,24,25,26)
Standard InChI Key: ZBMKZEUYRJLXFA-UHFFFAOYSA-N
Associated Targets(Human)
Casein kinase II alpha'/ beta 96 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 358.79 | Molecular Weight (Monoisotopic): 358.0734 | AlogP: 4.28 | #Rotatable Bonds: 2 |
| Polar Surface Area: 80.24 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.36 | CX Basic pKa: 4.33 | CX LogP: 3.28 | CX LogD: 2.22 |
| Aromatic Rings: 5 | Heavy Atoms: 26 | QED Weighted: 0.48 | Np Likeness Score: -1.41 |
References
| 1. Haddach M, Pierre F, Regan CF, Borsan C, Michaux J, Stefan E, Kerdoncuff P, Schwaebe MK, Chua PC, Siddiqui-Jain A, Macalino D, Drygin D, O'Brien SE, Rice WG, Ryckman DM.. (2012) Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs., 22 (1): [PMID:22169261] [10.1016/j.bmcl.2011.11.087] |
Source
Source(1):